What is the appropriate diagnostic and therapeutic approach for a patient presenting with intermittent fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Vignette: Intermittent Fever in a Critically Ill Patient

Patient Presentation

A 58-year-old man with a history of aortic valve replacement 3 years ago presents to the ICU on post-operative day 5 following exploratory laparotomy for bowel obstruction. He develops fever to 39.2°C (102.6°F) that occurs intermittently every 12-18 hours, with periods of defervescence in between. 1

Initial Clinical Features

  • Vital signs during febrile episodes: Temperature 39.2°C, heart rate 118 bpm, blood pressure 142/88 mmHg, respiratory rate 22 breaths/min, oxygen saturation 94% on 2L nasal cannula 1
  • Physical examination reveals: Surgical wound with minimal erythema, no purulent drainage; scattered crackles in bilateral lung bases; no new cardiac murmurs; abdomen soft with mild tenderness at incision site 1, 2
  • Medications: Vancomycin and piperacillin-tazobactam started empirically on post-op day 3 for suspected surgical site infection 1

Diagnostic Workup Sequence

Day 5 (Initial Fever Episode)

Immediate actions performed before any imaging or extended workup: 1

  • Blood cultures obtained from two separate sites before any antibiotic changes
  • Complete blood count showing WBC 14,200/μL with 82% neutrophils
  • Comprehensive metabolic panel revealing mild transaminase elevation (ALT 78 U/L, AST 92 U/L)
  • Urinalysis and urine culture sent
  • Bedside chest radiography performed showing bilateral lower lobe opacities, unchanged from post-operative baseline 1

Day 6 (Persistent Intermittent Fever)

Because fever persists beyond 48 hours despite broad-spectrum antibiotics, escalated diagnostic approach initiated: 1

  • Serum procalcitonin level: 3.2 ng/mL (suggesting bacterial infection rather than non-infectious cause) 1
  • Abdominal ultrasound performed given the transaminase elevation and recent abdominal surgery, revealing gallbladder wall thickening suggestive of acalculous cholecystitis 1
  • Blood cultures from Day 5 remain negative at 48 hours

Day 7 (Continued Fever with New Findings)

CT abdomen/pelvis with IV contrast ordered in collaboration with surgical team (as recommended for post-surgical patients without readily identified etiology): 1

  • Confirms acalculous cholecystitis with pericholecystic fluid
  • Reveals small fluid collection adjacent to surgical anastomosis site
  • No evidence of bowel perforation or abscess formation requiring immediate drainage

Day 8-9 (Broadening Differential)

Given prosthetic valve and persistent fever despite appropriate antibiotics: 1

  • Transthoracic echocardiogram performed showing no vegetations, normal valve function
  • Repeat blood cultures (third set) obtained
  • Fungal serologies sent including 1,3-β-D-glucan and galactomannan (given prolonged antibiotic exposure and ICU stay) 1
  • Q fever serologies ordered given valve history and fever pattern (phase I and phase II IgG antibodies) 1

Clinical Course and Diagnosis

Days 10-12

  • Percutaneous cholecystostomy tube placed by interventional radiology with drainage of purulent bile
  • Bile culture grows Enterococcus faecalis and Klebsiella pneumoniae
  • Antibiotic regimen adjusted to ampicillin-sulbactam based on susceptibilities
  • Fever pattern begins to improve 36 hours after drainage procedure 1

Day 14

  • Patient defervesces completely
  • Inflammatory markers trending down (procalcitonin 0.8 ng/mL, WBC 9,200/μL)
  • Q fever serologies return negative
  • Fungal markers negative 1

Follow-Up Monitoring Plan

Given prosthetic valve and acute Q fever ruled out, but patient remains at lifelong risk: 1

  • Serologic monitoring scheduled at 3,6,12,18, and 24 months post-infection
  • Patient counseled to seek immediate medical attention for any future fever, fatigue, or new cardiac symptoms
  • Baseline ophthalmologic examination not needed (hydroxychloroquine not indicated as Q fever excluded) 1, 3
  • Antibiotic course completed for 14 days total after source control 1

Key Clinical Pearls from This Case

This vignette demonstrates the algorithmic approach to intermittent fever in ICU patients: 1

  • Initial bedside chest radiography performed despite low positive predictive value, as pneumonia remains most common ICU infection
  • CT imaging pursued early in post-surgical patient when initial workup non-revealing
  • High-risk features (prosthetic valve) prompted extended infectious workup including Q fever serologies
  • Source control (cholecystostomy) proved essential when antibiotics alone failed
  • Procalcitonin helped distinguish bacterial infection from non-infectious fever causes 1

The intermittent fever pattern did not exclude serious infection and required persistent diagnostic evaluation until source identified. 1, 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fever in acute and critical care: a diagnostic approach.

AACN advanced critical care, 2014

Guideline

Hydroxychloroquine's Role in Fever Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of fever in the emergency department.

The American journal of emergency medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.